BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2944679)

  • 1. Renal vascular responses to saralasin in conscious chemically denervated rabbits and patients with tetraplegia.
    Unwin RJ; Mathias CJ; Peart WS; Frankel HL
    Clin Exp Hypertens A; 1986; 8(6):919-39. PubMed ID: 2944679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immediate pressor response to saralasin in man: evidence against sympathetic activation and for intrinsic angiotensin II-like myotropism.
    Mathias CJ; Unwin RJ; Pike FA; Frankel HL; Sever PS; Peart WS
    Clin Sci (Lond); 1984 May; 66(5):517-24. PubMed ID: 6231156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sympathetic and renin-angiotensin system influence on blood pressure and renal blood flow of two-kidney, one clip Goldblatt hypertensive dog.
    Zimmerman BG; Mommsen C; Kraft E
    Hypertension; 1980; 2(1):53-62. PubMed ID: 6989757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of saralasin infusion on bilateral renal function in two-kidney, one-clip Goldblatt hypertensive rats.
    Huang WC; Ploth DW; Navar LG
    Clin Sci (Lond); 1982 Jun; 62(6):573-9. PubMed ID: 7083749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The actions of saralasin on the renal circulation of man and dog; evidence for a sympathetic neural component to vasoconstriction.
    Wilcox CS; Lewis PS; Sever PS; Peart WS
    Eur J Clin Invest; 1981 Apr; 11(2 Suppl 1):77-83. PubMed ID: 6785099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of an angiotensin blocker (saralasin) on kidney function in dehydrated sheep.
    Yesberg NE; Henderson M; Wilson K; Law S; Cross RB
    Q J Exp Physiol; 1982 Jan; 67(1):97-103. PubMed ID: 7079453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Action of the competitive angiotensin II antagonist saralasin during the initial phase of glycerol-induced acute renal failure of the rat.
    Greven J; Klein H
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Dec; 301(2):139-43. PubMed ID: 600326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of the renin-angiotensin system on the autoregulation of renal blood flow and glomerular filtration rate in conscious dogs.
    Persson P; Ehmke H; Kirchheim H
    Acta Physiol Scand; 1988 Sep; 134(1):1-7. PubMed ID: 3239413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of angiotensin antagonists on renal vascular resistance and prostaglandin E release.
    Sugawara S; Zimmerman BG
    Clin Exp Hypertens (1978); 1978; 1(1):11-24. PubMed ID: 755643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesterol feeding does not alter renal hemodynamic response to acetylcholine and angiotensin II in rabbits.
    Carroll JF; Mizelle HL; Cockrell K; Reckelhoff JF; Clower BR; Granger JP
    Am J Physiol; 1997 Mar; 272(3 Pt 2):R940-7. PubMed ID: 9087658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II inhibition on blood pressure and renal hemodynamics in pregnant rats.
    Baylis C; Collins RC
    Am J Physiol; 1986 Feb; 250(2 Pt 2):F308-14. PubMed ID: 3511733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of adrenergic mediation of agonist response to [Sar1,Ala8]angiotensin II in conscious normotensive and hypertensive dogs.
    Zimmerman BG
    Clin Sci (Lond); 1979 Jul; 57(1):71-81. PubMed ID: 38941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance to blockade by saralasin of effect of ACE inhibitors in conscious sodium-restricted dog.
    Zimmerman BG; Goering JL; Raich PC
    Am J Physiol; 1988 Nov; 255(5 Pt 2):F944-52. PubMed ID: 2847552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of the decreased renal blood flow in the potassium-depleted conscious rat.
    Linas SL; Dickmann D
    Kidney Int; 1982 May; 21(5):757-64. PubMed ID: 6180215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal vascular responses to infusions of 1-sarcosine-8-alanine-angiotensin II (saralasin) in man and dog [proceedings].
    Lewis PS; Wilcox CS
    J Physiol; 1978 Jul; 280():42P-43P. PubMed ID: 690897
    [No Abstract]   [Full Text] [Related]  

  • 16. Control of renal function by intrarenal angiotensin II.
    Levens NR; Freedlender AE; Peach MJ; Carey RM
    Endocrinology; 1983 Jan; 112(1):43-9. PubMed ID: 6847833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of sar1ala8-angiotensin II in vasopressin-treated dehydrated sheep.
    Kelly C; Wholohan T; Yesberg NE
    Q J Exp Physiol; 1983 Apr; 68(2):161-6. PubMed ID: 6856746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of action of vasoconstrictor responses to atriopeptin II in conscious SHR.
    Lappe RW; Todt JA; Wendt RL
    Am J Physiol; 1985 Dec; 249(6 Pt 2):R781-6. PubMed ID: 2933964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative contribution of vasopressin and angiotensin II to the altered renal microcirculatory dynamics in two-kidney Goldblatt hypertension.
    Ichikawa I; Ferrone RA; Duchin KL; Manning M; Dzau VJ; Brenner BM
    Circ Res; 1983 Nov; 53(5):592-602. PubMed ID: 6194914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin receptors in glomeruli differ from those in renal arterioles.
    Caldicott WJ; Taub KJ; Margulies SS; Hollenberg NK
    Kidney Int; 1981 May; 19(5):687-93. PubMed ID: 6270445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.